PagnatoKarp Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,479
Closed -$479K 91
2020
Q1
$479K Sell
6,479
-309
-5% -$24.3K 0.12% 93
2019
Q4
$593K Sell
6,788
-385
-5% -$31.6K 0.1% 93
2019
Q3
$580K Buy
7,173
+109
+2% +$8.74K 0.12% 91
2019
Q2
$569K Sell
7,064
-265
-4% -$20.3K 0.12% 93
2019
Q1
$585K Sell
7,329
-148
-2% -$11.1K 0.13% 91
2018
Q4
$549K Buy
7,477
+4
+0.1% +$282 0.12% 81
2018
Q3
$509K Buy
7,473
+510
+7% +$32.5K 0.15% 89
2018
Q2
$406K Sell
6,963
-695
-9% -$39.2K 0.13% 93
2018
Q1
$400K Sell
7,658
-2,540
-25% -$137K 0.17% 88
2017
Q4
$552K Sell
10,198
-80
-0.8% -$4.43K 0.16% 83
2017
Q3
$633K Buy
10,278
+570
+6% +$34.6K 0.16% 73
2017
Q2
$598K Buy
9,708
+681
+8% +$41.5K 0.18% 72
2017
Q1
$551K Buy
9,027
+52
+0.6% +$3.15K 0.16% 70
2016
Q4
$509K Buy
+8,975
New +$525K 0.15% 74

Other funds holding MRK

PagnatoKarp Partners's MRK Position: Q2 2020 in Review

PagnatoKarp Partners sold out of Merck (MRK) in Q2 2020, closing a stake of 6,479 shares — an estimated $479K sold.

PagnatoKarp Partners first reported a position in MRK in Q4 2016 and held it in 14 quarters. The position peaked at $633K in Q3 2017. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • PagnatoKarp Partners reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • PagnatoKarp Partners sold 6,479 Merck shares in Q2 2020, an estimated $479K.
  • PagnatoKarp Partners first reported a position in Merck in Q4 2016 and held it in 14 quarters.
  • PagnatoKarp Partners's Merck position peaked at $633K in Q3 2017.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.